Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

3.07
Delayed Data
As of Aug 24
 -0.11 / -3.46%
Today’s Change
1.24
Today|||52-Week Range
3.46
+62.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$654.0M

Company Description

Amarin Corp. Plc is a biopharmaceutical company, which engages in the commercialization and development of therapeutics to improve cardiovascular health. Its product, Vascepa capsules, is use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Contact Information

Amarin Corp. Plc
2 Pembroke House
Dublin Dublin 00200
P:(531) 669-9020
Investor Relations:

Employees

Shareholders

Mutual fund holders7.30%
Individual stakeholders4.65%
Other institutional13.73%

Top Executives

John F. TheroPresident, Chief Executive Officer & Director
Michael W. KalbSenior VP, Chief Financial & Accounting Officer
Steven B. KetchumChief Scientific Officer
Craig B. GranowitzChief Medical Officer
Joseph T. KennedySecretary, Chief Compliance Officer & Senior VP